{
    "2020-11-13": [
        [
            {
                "time": "",
                "original_text": "深圳医药行业上市公司成立专业委员会",
                "features": {
                    "keywords": [
                        "深圳",
                        "医药",
                        "专业委员会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)4名董监将其间接持有部分公司股票转至个人名下并增持",
                "features": {
                    "keywords": [
                        "华大基因",
                        "董监",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "粤港澳大湾区最具创新力榜单：医药与生命科学TOP30",
                "features": {
                    "keywords": [
                        "粤港澳大湾区",
                        "创新力",
                        "医药",
                        "生命科学"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生命科学"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因：子公司新冠病毒核酸检测产品获巴西ANVISA认证",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠病毒",
                        "核酸检测",
                        "巴西",
                        "ANVISA认证"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：华大投资其合伙企业认缴出资金额变更为2941.25万元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "华大投资",
                        "出资金额变更"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因公告，全资子公司华大生物科技（武汉）有限公司的新型冠状病毒核酸检测试剂盒获得了巴西国家卫生监督局的认证",
                "features": {
                    "keywords": [
                        "华大基因",
                        "核酸检测试剂盒",
                        "巴西",
                        "认证"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)：新型冠状病毒2019-nCoV核酸检测试剂盒(荧光PCR法)获得巴西ANVISA认证",
                "features": {
                    "keywords": [
                        "华大基因",
                        "核酸检测试剂盒",
                        "荧光PCR法",
                        "巴西",
                        "ANVISA认证"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "深圳上市公司协会会员“圆桌会议”暨“走进华大基因”活动顺利举行",
                "features": {
                    "keywords": [
                        "深圳上市公司协会",
                        "圆桌会议",
                        "华大基因"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗健康产业2021年投资策略：医疗投资迎来长跑期 关注医保控费下的新机遇",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "投资策略",
                        "医保控费",
                        "新机遇"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}